Similar articles

• Resolution of renal failure with malignant hypertension in scleroderma. Case report and review of the literature.

  Simon NM, Graham MB, Kyser FA, Gashti EN. Simon NM, et al. Am J Med. 1979 Sep;67(3):533-9. doi: 10.1016/0002-9343(79)90807-6. Am J Med. 1979. PMID: 474603 No abstract available.
• Clinicopathologic conference. Recurrent hematuria with late hypertension and renal failure.

  [No authors listed] [No authors listed] Am J Med. 1978 Oct;65(4):679-90. doi: 10.1016/0002-9343(78)90857-4. Am J Med. 1978. PMID: 707527 No abstract available.
• [Management of malignant hypertension].

  Olmer M, Salvadori JM, Grandvuillemin M, Ducros J, Bouvenot G. Olmer M, et al. Mars Med. 1971;108(11):805-12. Mars Med. 1971. PMID: 4945701 French. No abstract available.
• [Malignant hypertension. Significance of hypovolemia in pathogenesis and therapy of malignant hypertension].

  Orth H, Möhring J, Ritz E. Orth H, et al. Dtsch Med Wochenschr. 1976 Nov 5;101(45):1655-9. doi: 10.1055/s-0028-1104319. Dtsch Med Wochenschr. 1976. PMID: 791604 Review. German. No abstract available.
• Progress report: hepatitis-associated (Australia) antigen.

  Sherlock S. Sherlock S. Gut. 1970 Feb;11(2):185-8. doi: 10.1136/gut.11.2.185. Gut. 1970. PMID: 4246670 Free PMC article. Review. No abstract available.